Genome & Company (KOSDAQ:314130)
South Korea · Delayed Price · Currency is KRW 6,430.00
-170.00 (-2.58%)
At close: May 20, 2026
Genome & Company Market Cap
Genome & Company has a market cap or net worth of 232.5 billion as of May 21, 2026. Its market cap has increased by 146.85% in one year.
Market Cap
232.50B
Enterprise Value
228.13B
Revenue
24.59B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,430.00
Market Cap Chart
Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 232.50B, an increase of 223.47%. That is a compound annual growth rate of 17.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 232.50B | -2.47% |
| Dec 30, 2025 | 238.38B | 179.77% |
| Dec 30, 2024 | 85.21B | -51.64% |
| Dec 28, 2023 | 176.21B | -28.34% |
| Dec 29, 2022 | 245.90B | -47.55% |
| Dec 30, 2021 | 468.83B | -55.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acryl | 236.09B |
| Unison | 235.98B |
| NIBEC | 235.88B |
| Namuga | 235.20B |
| Korea Alcohol Industrial | 235.08B |
| SAMG Entertainment | 234.57B |
| Interojo | 231.70B |
| DAEA TI | 231.15B |